Search the Newsreel

Organon (OGN) Lags Q2 Earnings Estimates

Organon (OGN) came out with quarterly earnings of $0.85 per share, missing the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $1 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Organon declares $0.02 quarterly dividend per share

Organon & Co. (NYSE: OGN) has announced a quarterly dividend of $0.02 per share of common stock. This dividend is scheduled to be paid on September 10, 2026, to shareholders recorded by August 14, 2026. Organon is a healthcare company based in Jersey City, …

Organon: Q2 Earnings Snapshot

Organon & Co. 2026: Revenue $1.56B, EPS $0.4— 10-Q Summary

Organon & Co. reported its 2026 quarterly results, showing a decline in revenue, net income, and diluted EPS compared to the prior-year quarter. Revenue was $1.56 billion, with a diluted EPS of $0.4. The company is in the process of being acquired by Sun …

CGNX|Cognex Corp|Price:65.240|Chg%:+2.620

Cognex Corp's stock (CGNX) closed at $65.24, up 4.18%, with a market cap of $10.86 billion. The company exhibits strong fundamentals, including high revenue growth and a stable dividend, and is considered fairly valued by analysts. Despite some institutional selling, the stock is rated …

Cognizant Technology Solutions (CTSH) Stock Faces Margin Questions Despite AI Progress

Orographic Financial Advisors LLC Acquires New Holdings in Organon & Co. $OGN

Organon & Co. (NYSE:OGN) Issues Earnings Results, Misses Expectations By $0.02 EPS

Organon & Co. (NYSE:OGN) to Issue $0.02 Quarterly Dividend

Organon & Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Alpha Cognition Inc (ACOG) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Alpha Cognition Inc (ACOG), noting its current valuation score of 6.36 and ranking within the Pharmaceuticals industry. It highlights the company's P/E ratio of -6.42 and states that relevant data for P/B, P/S, and P/CF ratios have …

A Look at Cognex Corp (CGNX) After 8.3% Gain -- GF Value $51.51 vs Price $62.64

Cognex Corp (CGNX) shares recently gained 8.3% but are considered overvalued, with a GF Value of $51.51 against a current price of $62.64. The company holds a strong GF Score of 83/100 due to high profitability and financial strength, though growth and momentum ranks …

Is Alpha Cognition (NASDAQ:ACOG) In A Good Position To Invest In Growth?

Alpha Cognition (NASDAQ: ACOG) has a cash runway of about 21 months with US$54m in cash and US$30m annual cash burn, and analysts expect it to break even in about 3 years. The company's cash burn increased significantly by 309%, but this was accompanied …

Morgan Stanley Just Upped Its Price Target on Cognizant Stock. Here's Why.

Stock brokers analyzing stocks on screen by Standret via Shutterstock Cognizant (CTSH) stock is in the red on July 30 even after a senior Morgan Stanley analyst raised his price target on the Teaneck-headquartered IT services company. Investors aren't cheering CTSH primarily because James …

Cognizant Q2 Earnings Miss Estimates, Revenues Beat, Rise Y/Y

Cognizant Technology Solutions CTSH reported second-quarter 2026 adjusted earnings of $1.37 per share, up 4.6% year over year, but lagging the Zacks Consensus Estimate by 0.7%. Higher interest expense related to Astreya acquisition funding and share repurchases weighed on earnings. Revenues of $5.48 billion …

Cognizant Has Opportunity to Help Clients Find Value From AI Investments, Wedbush Says

Cognizant Technology Solutions (CTSH) is in the early stages of its AI Builder strategy, with an opp PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade …

Cognyte Calls September Shareholder Meeting as Strong Fiscal 2026 Results Bolster Market Position

Cognyte Software announced it will hold its Annual General Meeting on September 3, 2026, following strong fiscal year 2026 results which include a 14% revenue increase to $400 million and a 66% rise in adjusted EBITDA. The company, which provides AI-powered investigative analytics, also …

Cognizant Technology Solutions (CTSH) Following Results And Guidance Faces An Undervalued Narrative

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Cognizant Technology Solutions (CTSH) has just combined a fresh quarterly cash dividend declaration with …

Cognizant Q2 Earnings Call Focuses on AI Builder Shift

Cognizant Technology Solutions Corporation CTSH used its second-quarter earnings call to emphasize its transition from a traditional technology services provider toward an AI-focused operating model. Management highlighted expanding AI capabilities, large deal momentum and platform-led growth opportunities. The company reported adjusted earnings per share …

OGN|Organon & Co|Price:13.550|Chg%:+0.030

Organon & Co (OGN) stock currently trades at $13.545, with its fundamentals described as stable and growth potential high. TradingKey rates its valuation as "fairly valued" within the Pharmaceuticals industry, although it notes the stock is considered overvalued based on its PE ratio. Institutional …

Does Cognizant (CTSH) Turning AI Deals And Dividends Into A Durable Competitive Edge?

Cognizant Technology Solutions recently reported past second-quarter 2026 results showing sales of US$5,481 million and net income of US$636 million, while also affirming a quarterly cash dividend of US$0.33 per share payable on August 25, 2026. Alongside these financials, Cognizant expanded its AI footprint …

Organon & Co. (NYSE:OGN) Receives Average Rating of "Reduce" from Brokerages

Sera Prognostics Q1 2026 Earnings: EPS Matches Estimates With Shares Up 2.44% - Low Growth Earnings

First Trust Advisors LP Has $19.33 Million Position in Organon & Co. $OGN

Cognition Therapeutics (CGTX) to Post Quarterly Earnings on Thursday

Cognizant Technology Solutions Corp Class A (CTSH) brings a 13.5% four-week rebound into earnings

The July 29 report will test whether recent strength can offset a weaker 12-week tape and subdued relative strength.

Cognizant Technology Solutions Corp (CTSH) Q2 2026 Earnings Call Highlights: Strong Revenue ...

This article first appeared on GuruFocus. Revenue: $5.5 billion, up 4.1% year over year in constant currency. Adjusted Operating Margin: 16%, up 40 basis points year over year. Adjusted EPS: $1.37, up 5% year over year. Free Cash Flow: $459 million for the second …

Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary

Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary - Moby Strategic Performance and Operational Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. …

Cognyte Software (CGNT) details FY26 gains and 2026 shareholder meeting

Cognyte Software (CGNT) announced its Annual General Meeting to be held on September 3, 2026, where shareholders will vote on re-electing directors and reappointing auditors. The company reported strong financial results for fiscal year 2026, with revenue up 14.1% to $400.0 million and Adjusted …

Cognizant Earnings: Financial Services and North America Drive Resilient Performance

Cognizant Technology Solutions posted resilient second-quarter results driven by strong performances in North America and financial services, with constant currency revenue growth topping that of Indian IT consultants. The company's financial services segment saw double-digit growth, bolstered by AI adoption and expanding partnerships with …

¿Sigue siendo Cognizant Technology Solutions (CTSH) una ganga a la vista de sus resultados?

Can Cognizant Technology Solutions (CTSH) Still Be A Bargain On Earnings?

Earnings call transcript: Cognizant tops revenue view in Q2 2026, shares rise

Cognizant Technology Solutions reported Q2 2026 revenue of $5.5 billion, beating expectations, with adjusted EPS narrowly missing Wall Street estimates. The company's shares rose in premarket trading as investors reacted positively to an improved full-year profit outlook, consistent margin gains, and expanding AI-related work. …

Alpha Cognition receives European patent for Alzheimer’s drug

Alpha Cognition Inc. has been granted a European patent for a crystalline solid form of benzgalantamine, the active ingredient in its Alzheimer's drug ZUNVEYL. This patent could provide protection until 2042 across various European markets. The company, a biopharmaceutical firm, is focused on developing …

Cognizant (CTSH) Lags Q2 Earnings Estimates

Cognizant (CTSH) came out with quarterly earnings of $1.37 per share, missing the Zacks Consensus Estimate of $1.38 per share. This compares to earnings of $1.31 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Watch Cognex CFO's Aug. 10 fireside chat live online or later

Cognex Corporation (NASDAQ: CGNX) announced that its Chief Financial Officer, Dennis Fehr, will participate in a fireside chat at the KeyBanc Technology Leadership Forum on Monday, August 10, 2026, at 9:30 a.m. Mountain Time. A live webcast and replay of the event will be …